Alshad S. Lalani

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 752 citations · Full text

Tumor Biology, Oncology, Medicine +8

HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers

Bob T. Li, Flavia Michelini, Sandra Misale et al. · Cancer Discovery · 2020 · 274 citations · Full text

Inhibition of Lymphogenous Metastasis Using Adeno-Associated Virus-Mediated Gene Transfer of a Soluble VEGFR-3 Decoy Receptor

Jianmin Lin, Alshad S. Lalani, Thomas C. Harding et al. · Cancer Research · 2005 · 266 citations · Full text

Angiogenesis, Oncology, Medicine +13

Vascular Endothelial Growth Factor Blockade Reduces Intratumoral Regulatory T Cells and Enhances the Efficacy of a GM-CSF–Secreting Cancer Immunotherapy

Betty Li, Alshad S. Lalani, Thomas C. Harding et al. · Clinical Cancer Research · 2006 · 231 citations

Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition

Christopher Daly, Alexandra Eichten, Carla Castanaro et al. · Cancer Research · 2012 · 225 citations · Full text

Immunology, Angiopoietin-2 Functions, Pharmacotherapy +17